NUR INK INNOVATIONS LTD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,376 ILa | +0.22% |
|
-0.72% | +30.18% |
| 03-28 | Nur Ink Innovations Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Nur Ink Innovations Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Capitalization 1 | 318.7 | 157.4 | 53.72 |
| Enterprise Value (EV) 1 | 289.7 | 139.7 | 46.49 |
| P/E ratio | -34.9 x | -13.6 x | - |
| Yield | - | - | - |
| Capitalization / Revenue | - | - | - |
| EV / Revenue | - | - | - |
| EV / EBITDA | -41 x | -12.6 x | -4.1 x |
| EV / FCF | -40,532,014 x | -17,828,602 x | -6,077,062 x |
| FCF Yield | -0% | -0% | -0% |
| Price to Book | 8.95 x | 5.69 x | - |
| Nbr of stocks (in thousands) | 5,060 | 5,060 | 5,082 |
| Reference price 2 | 62.99 | 31.11 | 10.57 |
| Announcement Date | 30/03/23 | 30/03/23 | 28/03/24 |
1ILS in Million2ILS
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Net sales | - | - | - | - | - |
| EBITDA 1 | -1.87 | -3.043 | -7.075 | -11.09 | -11.35 |
| EBIT 1 | -1.879 | -3.223 | -7.289 | -11.5 | -13.07 |
| Operating Margin | - | - | - | - | - |
| Earnings before Tax (EBT) 1 | -1.883 | -4.054 | -7.781 | -11.61 | -12.86 |
| Net income 1 | -1.883 | -4.054 | -7.781 | -11.61 | -12.86 |
| Net margin | - | - | - | - | - |
| EPS 2 | -12.79 | -13.25 | -1.806 | -2.289 | - |
| Free Cash Flow | - | -1.887 | -7.148 | -7.833 | -7.65 |
| FCF margin | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 25/04/21 | 25/04/21 | 30/03/23 | 30/03/23 | 28/03/24 |
1ILS in Million2ILS
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Net Debt 1 | - | 1.36 | - | - | - |
| Net Cash position 1 | 0.79 | - | 29 | 17.8 | 7.23 |
| Leverage (Debt/EBITDA) | - | -0.4473 x | - | - | - |
| Free Cash Flow | - | -1.89 | -7.15 | -7.83 | -7.65 |
| ROE (net income / shareholders' equity) | - | -4,480% | -44.8% | -36.5% | -58.6% |
| ROA (Net income/ Total Assets) | - | -140% | -21.5% | -19.3% | -29.6% |
| Assets 1 | - | 2.903 | 36.21 | 60.08 | 43.4 |
| Book Value Per Share 2 | 8.230 | -3.200 | 7.030 | 5.470 | - |
| Cash Flow per Share 2 | 5.000 | 0.5700 | 6.460 | 2.310 | - |
| Capex 1 | 0.52 | 0.22 | 2.78 | 1.82 | 0.85 |
| Capex / Sales | - | - | - | - | - |
| Announcement Date | 25/04/21 | 25/04/21 | 30/03/23 | 30/03/23 | 28/03/24 |
1ILS in Million2ILS
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +30.18% | 18.91M | |
| +12.26% | 4.02B | |
| +14.31% | 1.92B | |
| +24.00% | 1.11B | |
| +9.51% | 1.03B | |
| +30.37% | 770M | |
| +56.91% | 717M | |
| -7.31% | 655M | |
| +34.08% | 598M | |
| +25.85% | 550M |
- Stock Market
- Equities
- NURI Stock
- Financials Nur Ink Innovations Ltd
